Literature DB >> 33223527

Genomic profiling of T-cell activation suggests increased sensitivity of memory T cells to CD28 costimulation.

Dafni A Glinos1,2, Blagoje Soskic1,3, Cayman Williams4, Alan Kennedy4, Luke Jostins5,6,7, David M Sansom8, Gosia Trynka9,10.   

Abstract

T-cell activation is a critical driver of immune responses. The CD28 costimulation is an essential regulator of CD4 T-cell responses, however, its relative importance in naive and memory T cells is not fully understood. Using different model systems, we observe that human memory T cells are more sensitive to CD28 costimulation than naive T cells. To deconvolute how the T-cell receptor (TCR) and CD28 orchestrate activation of human T cells, we stimulate cells using varying intensities of TCR and CD28 and profiled gene expression. We show that genes involved in cell cycle progression and division are CD28-driven in memory cells, but under TCR control in naive cells. We further demonstrate that T-helper differentiation and cytokine expression are controlled by CD28. Using chromatin accessibility profiling, we observe that AP1 transcriptional regulation is enriched when both TCR and CD28 are engaged, whereas open chromatin near CD28-sensitive genes is enriched for NF-kB motifs. Lastly, we show that CD28-sensitive genes are enriched in GWAS regions associated with immune diseases, implicating a role for CD28 in disease development. Our study provides important insights into the differential role of costimulation in naive and memory T-cell responses and disease susceptibility.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33223527      PMCID: PMC7785515          DOI: 10.1038/s41435-020-00118-0

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  76 in total

1.  The sva package for removing batch effects and other unwanted variation in high-throughput experiments.

Authors:  Jeffrey T Leek; W Evan Johnson; Hilary S Parker; Andrew E Jaffe; John D Storey
Journal:  Bioinformatics       Date:  2012-01-17       Impact factor: 6.937

2.  Induction of autoimmune disease in CTLA-4-/- mice depends on a specific CD28 motif that is required for in vivo costimulation.

Authors:  Xuguang Tai; Francois Van Laethem; Arlene H Sharpe; Alfred Singer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-16       Impact factor: 11.205

3.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Bioinformatics       Date:  2013-11-13       Impact factor: 6.937

4.  CD28 days later: Resurrecting costimulation for CD8(+) memory T cells.

Authors:  Verena van der Heide; Dirk Homann
Journal:  Eur J Immunol       Date:  2016-07       Impact factor: 5.532

5.  Induction of activator protein (AP)-1 and nuclear factor-kappaB by CD28 stimulation involves both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals.

Authors:  C E Edmead; Y I Patel; A Wilson; G Boulougouris; N D Hall; S G Ward; D M Sansom
Journal:  J Immunol       Date:  1996-10-15       Impact factor: 5.422

6.  T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition.

Authors:  Enfu Hui; Jeanne Cheung; Jing Zhu; Xiaolei Su; Marcus J Taylor; Heidi A Wallweber; Dibyendu K Sasmal; Jun Huang; Jeong M Kim; Ira Mellman; Ronald D Vale
Journal:  Science       Date:  2017-03-09       Impact factor: 47.728

7.  Interrupting CD28 costimulation before antigen rechallenge affects CD8(+) T-cell expansion and effector functions during secondary response in mice.

Authors:  Monika Fröhlich; Tea Gogishvili; Daniela Langenhorst; Fred Lühder; Thomas Hünig
Journal:  Eur J Immunol       Date:  2016-05-17       Impact factor: 5.532

8.  Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.

Authors:  Iris E Jansen; Jeanne E Savage; Stephan Ripke; Ole A Andreassen; Danielle Posthuma; Kyoko Watanabe; Julien Bryois; Dylan M Williams; Stacy Steinberg; Julia Sealock; Ida K Karlsson; Sara Hägg; Lavinia Athanasiu; Nicola Voyle; Petroula Proitsi; Aree Witoelar; Sven Stringer; Dag Aarsland; Ina S Almdahl; Fred Andersen; Sverre Bergh; Francesco Bettella; Sigurbjorn Bjornsson; Anne Brækhus; Geir Bråthen; Christiaan de Leeuw; Rahul S Desikan; Srdjan Djurovic; Logan Dumitrescu; Tormod Fladby; Timothy J Hohman; Palmi V Jonsson; Steven J Kiddle; Arvid Rongve; Ingvild Saltvedt; Sigrid B Sando; Geir Selbæk; Maryam Shoai; Nathan G Skene; Jon Snaedal; Eystein Stordal; Ingun D Ulstein; Yunpeng Wang; Linda R White; John Hardy; Jens Hjerling-Leffler; Patrick F Sullivan; Wiesje M van der Flier; Richard Dobson; Lea K Davis; Hreinn Stefansson; Kari Stefansson; Nancy L Pedersen
Journal:  Nat Genet       Date:  2019-01-07       Impact factor: 38.330

9.  Genetic and epigenetic fine mapping of causal autoimmune disease variants.

Authors:  Kyle Kai-How Farh; Alexander Marson; Jiang Zhu; Markus Kleinewietfeld; William J Housley; Samantha Beik; Noam Shoresh; Holly Whitton; Russell J H Ryan; Alexander A Shishkin; Meital Hatan; Marlene J Carrasco-Alfonso; Dita Mayer; C John Luckey; Nikolaos A Patsopoulos; Philip L De Jager; Vijay K Kuchroo; Charles B Epstein; Mark J Daly; David A Hafler; Bradley E Bernstein
Journal:  Nature       Date:  2014-10-29       Impact factor: 49.962

10.  Systematic identification of trans eQTLs as putative drivers of known disease associations.

Authors:  Harm-Jan Westra; Marjolein J Peters; Tõnu Esko; Hanieh Yaghootkar; Claudia Schurmann; Johannes Kettunen; Mark W Christiansen; Bruce M Psaty; Samuli Ripatti; Alexander Teumer; Timothy M Frayling; Andres Metspalu; Joyce B J van Meurs; Lude Franke; Benjamin P Fairfax; Katharina Schramm; Joseph E Powell; Alexandra Zhernakova; Daria V Zhernakova; Jan H Veldink; Leonard H Van den Berg; Juha Karjalainen; Sebo Withoff; André G Uitterlinden; Albert Hofman; Fernando Rivadeneira; Peter A C 't Hoen; Eva Reinmaa; Krista Fischer; Mari Nelis; Lili Milani; David Melzer; Luigi Ferrucci; Andrew B Singleton; Dena G Hernandez; Michael A Nalls; Georg Homuth; Matthias Nauck; Dörte Radke; Uwe Völker; Markus Perola; Veikko Salomaa; Jennifer Brody; Astrid Suchy-Dicey; Sina A Gharib; Daniel A Enquobahrie; Thomas Lumley; Grant W Montgomery; Seiko Makino; Holger Prokisch; Christian Herder; Michael Roden; Harald Grallert; Thomas Meitinger; Konstantin Strauch; Yang Li; Ritsert C Jansen; Peter M Visscher; Julian C Knight
Journal:  Nat Genet       Date:  2013-09-08       Impact factor: 38.330

View more
  4 in total

1.  Immune disease risk variants regulate gene expression dynamics during CD4+ T cell activation.

Authors:  Blagoje Soskic; Eddie Cano-Gamez; Deborah J Smyth; Kirsty Ambridge; Ziying Ke; Julie C Matte; Lara Bossini-Castillo; Joanna Kaplanis; Lucia Ramirez-Navarro; Anna Lorenc; Nikolina Nakic; Jorge Esparza-Gordillo; Wendy Rowan; David Wille; David F Tough; Paola G Bronson; Gosia Trynka
Journal:  Nat Genet       Date:  2022-05-26       Impact factor: 41.307

2.  Therapeutic Potential of Ex Vivo Expanded γδ T Cells against Osteosarcoma Cells.

Authors:  Yunmi Ko; Yeon Ho Jeong; Jun Ah Lee
Journal:  Cells       Date:  2022-07-11       Impact factor: 7.666

3.  Single cell transcriptomics of Atlantic salmon (Salmo salar L.) liver reveals cellular heterogeneity and immunological responses to challenge by Aeromonas salmonicida.

Authors:  Richard S Taylor; Rose Ruiz Daniels; Ross Dobie; Shahmir Naseer; Thomas C Clark; Neil C Henderson; Pierre Boudinot; Samuel A M Martin; Daniel J Macqueen
Journal:  Front Immunol       Date:  2022-08-24       Impact factor: 8.786

4.  Removal of CD276+ cells from haploidentical memory T-cell grafts significantly lowers the risk of GVHD.

Authors:  Hisayoshi Hashimoto; Patrick Kasteleiner; Jakob Kressin; Friederike Müller; Hans-Jörg Bühring; Rupert Handgretinger; Karin Schilbach
Journal:  Bone Marrow Transplant       Date:  2021-05-11       Impact factor: 5.483

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.